Drug Trial Radar · NCT07046806
Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Last checked: Nov 19, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Mar 10, 2025
Primary completion
Apr 1, 2026
Study completion Apr 1, 2026
Sponsor
- Lead sponsor
- Institute for Asthma and AllergyResearch network
- Sponsor type
- Research network
- First posted
- Jul 2, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the efficacy of prophylactic treatment with deucrictibant extended release (XR) tablet versus placebo in preventing angioedema attacks, and to also assess the efficacy of deucrictibant soft capsules as on-demand treatment versus placebo in achieving angioedema symptom relief during acute attacks.
Conditions
- Hereditary Angioedema (HAE)
- Angioedema
- Bradykinin-mediated Angioedema
- C1 Inhibitor Deficiency
Interventions
Deucrictibant XR tabletDrug
Deucrictibant 40 mg XR tablet for prophylaxis
Placebo comparator to XR tabletDrug
Placebo comparator to deucrictibant 40 mg XR tablet, prophylaxis
Deucrictibant 20 mg capsuleDrug
Deucrictibant active drug for on-demand treatment of angioedma attacks
Placebo comparator to 20 mg capsuleDrug
Placebo comparator to Deucrictibant 20 mg capsule for on-demand treatment of angioedema attacks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part-1: Incidence and quality of HAE attacks comparing active versus placebo arms.Time frame: 24 weeks
- Part-2: Efficacy of active on-demand treatment versus placebo in achieving angioedema symptom relief during acute attacksTime frame: 16 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Institute For Asthma & Allergy
Wheaton, Maryland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.